IM Adrenaline 0.5 mL Should NOT Be Given to Hemodynamically Stable Patients Without Clear Indication
Administering intramuscular adrenaline to a hemodynamically stable patient is only appropriate when there is a clear diagnosis of anaphylaxis or another specific indication—hemodynamic stability alone does not justify its use, and giving it without proper indication exposes the patient to unnecessary cardiac risks. 1, 2
When IM Adrenaline IS Indicated
Adrenaline is indicated specifically for:
Anaphylaxis diagnosis confirmed by:
- Acute onset with skin/mucosal involvement PLUS respiratory compromise or hypotension/syncope 3
- Two or more organ systems involved after allergen exposure (skin, respiratory, cardiovascular, gastrointestinal) 3
- Isolated hypotension after known allergen exposure (even without skin signs, which are absent in 10% of cases) 3
Specific anaphylaxis triggers requiring immediate treatment:
- Respiratory symptoms: difficulty breathing, wheezing, throat tightness, stridor 4
- Cardiovascular symptoms: hypotension, dizziness, syncope, loss of consciousness 4
- Widespread urticaria with systemic symptoms after known allergen exposure 4
- Known allergen exposure in someone with previous anaphylaxis, even if symptoms are initially mild 4
Why NOT to Give Adrenaline to Stable Patients Without Indication
Adrenaline carries significant cardiac risks when used inappropriately:
- May produce ventricular arrhythmias, particularly in patients with underlying heart disease 2
- Can aggravate angina pectoris 2
- Increases myocardial oxygen demand, creating potential ischemia 1
- Adverse effects include anxiety, tremor, palpitations, and potentially fatal ventricular fibrillation 2
- Patients with hyperthyroidism, Parkinson's disease, diabetes, and pheochromocytoma are at greater risk of adverse reactions 2
Critical Distinction: Hemodynamically Stable WITH Anaphylaxis vs. Stable WITHOUT Anaphylaxis
If the patient is hemodynamically stable BUT has confirmed anaphylaxis, adrenaline SHOULD be given:
- Early adrenaline use in hemodynamically stable anaphylaxis patients reduces the risk of developing subsequent hypotension (OR 0.254,95% CI 0.091-0.706) 6
- Approximately 12% (40/340) of initially normotensive anaphylaxis patients develop hypotension during their ED stay 6
- Delayed epinephrine administration is associated with increased mortality and biphasic reactions 1, 4
- When in doubt about anaphylaxis diagnosis, err on the side of administering epinephrine—the risk of untreated anaphylaxis exceeds the risk of appropriate epinephrine use 4
If the patient is hemodynamically stable WITHOUT anaphylaxis, adrenaline should NOT be given:
- No indication exists for prophylactic or empiric adrenaline in stable patients 1, 2
- Iatrogenic overdose from confusion about dosing has caused life-threatening cardiac complications 5
- The risk-benefit ratio does not favor administration without clear indication 2
Correct Dosing IF Anaphylaxis Is Confirmed
For adults ≥30 kg with anaphylaxis:
- 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) IM into anterolateral thigh 1, 2
- Maximum single dose: 0.5 mg 1, 3
- Repeat every 5-10 minutes as needed if symptoms persist or worsen 1, 2
- 10-20% of patients require more than one dose 1, 3
Common Pitfalls to Avoid
- Do not confuse vasovagal reactions with anaphylaxis: Vasovagal events show pallor, weakness, nausea, diaphoresis, bradycardia, and hypotension WITHOUT skin manifestations (urticaria, angioedema, flush, pruritus) that are present in most anaphylaxis cases 1
- Do not use wrong concentration: 1:1000 (1 mg/mL) for IM use; 1:10,000 (0.1 mg/mL) for IV use only—confusion has caused fatal overdoses 7, 5
- Do not inject into wrong site: Use anterolateral thigh (vastus lateralis), NOT deltoid, buttocks, digits, hands, or feet 4, 2
- Do not substitute antihistamines or bronchodilators: These are adjunctive only and do not treat life-threatening manifestations 1, 4
Bottom Line Algorithm
Is there confirmed anaphylaxis? (acute onset with multi-system involvement or known allergen exposure with appropriate symptoms) 3
If anaphylaxis confirmed, monitor and repeat dosing every 5-10 minutes if symptoms persist or progress 1, 2
If patient fails to respond to multiple IM doses, escalate to IV epinephrine infusion (1:10,000 solution at 1-4 mcg/min) 3